The bill permits entities and organizations other than schools to acquire and stock epinephrine auto-injectors. A health care practitioner may prescribe, and a health care practitioner or pharmacist may dispense, epinephrine auto-injectors in the name of an authorized entity where allergens capable of causing anaphylaxis may be present. Each employee, agent, or other individual of the authorized entity must complete a training program before using an epinephrine auto-injector. A trained employee, agent, or other individual of the authorized entity may either provide or administer an epinephrine auto-injector to a person who the employee, agent, or other individual believes in good faith is experiencing anaphylaxis.
An authorized entity may keep an emergency public access station (EPAS) containing epinephrine auto-injectors under the general oversight of a medical professional who is capable of communicating with a user in real time before the EPAS may be unlocked to dispense an epinephrine auto-injector.
The bill exempts from civil and criminal liability:
- An authorized entity that possesses and makes available an epinephrine auto-injector or an EPAS and the entity's employees, agents, and other individuals;
- An individual or entity that conducts the anaphylaxis training program;
- An individual who prescribes or dispenses an epinephrine auto-injector;
- An individual who provides or administers an epinephrine auto-injector;
- A medical professional who consults a user of an EPAS and makes an epinephrine auto-injector stored in the EPAS available to the user; and
- An individual who uses an EPAS.